Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × poly ICLC × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Melanoma 4 Glioblastoma 3 Carcinoma 3 Fibrolamellar hepatocellular carcinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Squamous Cell 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

Cyclophosphamide 8 Biopsy 8 pembrolizumab 7 Specimen Handling 7 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Brentuximab Vedotin 6 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 fludarabine phosphate 4 duvelisib 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Etoposide 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡